LOM
PTLA

Loeb Offshore Management’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Loeb Offshore Management’s Portfolio PTLA Stock Details PTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-10,544
Closed -$272K – 225
2013
Q4 		$272K Buy
+10,544
New +$256K 0.08% 156

Other funds holding PTLA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Loeb Offshore Management's PTLA Position: Q1 2014 in Review

Loeb Offshore Management sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q1 2014, closing a stake of 10,544 shares — an estimated $272K sold.

Loeb Offshore Management first reported a position in PTLA in Q4 2013 and held it in 1 quarter. The position peaked at $272K in Q4 2013. 102 funds tracked by Wall St. Rank hold PTLA as of Q1 2014.

  • Loeb Offshore Management reported no remaining Portola Pharmaceuticals, Inc. position as of Q1 2014 after selling out during the quarter.
  • Loeb Offshore Management sold 10,544 Portola Pharmaceuticals, Inc. shares in Q1 2014, an estimated $272K.
  • Loeb Offshore Management first reported a position in Portola Pharmaceuticals, Inc. in Q4 2013 and held it in 1 quarter.
  • Loeb Offshore Management's Portola Pharmaceuticals, Inc. position peaked at $272K in Q4 2013.
  • 102 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q1 2014.

Based on Loeb Offshore Management's 13F filing for Q1 2014, filed 15 May 2014.